STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Biotechnology
chemistry

HCW Biologics Gains FDA Clearance for First-in-Human Trial of Novel Alopecia Areata Treatment

byLuca Blaumann
February 3, 2025
in Biotechnology, Small-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Phase 1 Trial of HCW9302 Marks a Milestone in Autoimmune Disease Research

HCW Biologics (HCWB), a clinical-stage biopharmaceutical company specializing in innovative immunotherapies, has announced FDA clearance for its Investigational New Drug Application (IND) to begin a first-in-human Phase 1 clinical trial of HCW9302. This trial will evaluate the drug’s safety and efficacy in patients suffering from moderate-to-severe alopecia areata, an autoimmune disease characterized by sudden hair loss and a significant impact on psychological well-being.

HCW9302 is a groundbreaking interleukin 2 (IL-2) fusion protein complex developed using HCW’s proprietary TOBI platform technology. It functions by binding to IL-2αβγ receptors, primarily found on regulatory T (Treg) cells, which helps activate and expand these cells to suppress harmful immune and inflammatory responses. This mechanism offers hope for patients who currently have no FDA-approved curative treatments for alopecia areata.

Preclinical models have demonstrated HCW9302’s efficacy in treating autoimmune diseases at well-tolerated doses, showing potential beyond alopecia areata. The injectable, subcutaneous approach aims to reduce inflammation while minimizing the risk of broad immunosuppression.

Dr. Hing C. Wong, Founder and CEO of HCW Biologics, expressed enthusiasm about the FDA’s decision, stating, “This clearance brings us one step closer to offering a transformative immunotherapeutic for autoimmune diseases. While alopecia areata is not life-threatening, its psychological toll is profound, and current treatments often carry severe side effects.”

The primary goal of the Phase 1 trial is to establish a safe and effective dose of HCW9302 that boosts Treg cell activity. Success in this phase could lead to expanded trials targeting other autoimmune and inflammatory conditions, including graft rejection, atherosclerosis, diabetes, and neurodegenerative diseases.

Read original press release here

You might like this article:Trump’s New Tariffs Spark Global Retaliation and Trade War Fears

Tags: BreakingGrowthMoversNewsStock Market
Previous Post

Trump’s New Tariffs Spark Global Retaliation and Trade War Fears

Next Post

Palantir Reports Record Q4 Results, Solidifies Role in AI Revolution

Related Posts

Regencell Bioscience’s Stock Whipsaws Again Amid 17,000% Surge in 2025

byLuca Blaumann
July 7, 2025
0

Following a 38-to-1 stock split and explosive rally, the biotech firm's volatile trading persists despite a multi-year loss streak Regencell...

trading-chart-2

BitMine Raises $250 Million to Launch One of the Largest Public Ether Treasuries

byLuca Blaumann
June 30, 2025
0

Ethereum-focused strategy attracts top crypto investors as BitMine stock surges on bold treasury pivot BitMine Immersion Technologies (BMNR) has announced...

EXCLUSIVE: MIRA Pharmaceuticals’ Disruptive Path In Neurology And Metabolic Disorders

byLiliana Vida
June 30, 2025
0

CEO Erez Aminov on Breakthrough Drug Candidates, Strategic Acquisitions, and the Vision Behind MIRA’s Innovation-Driven Pipeline MIRA Pharmaceuticals (NASDAQ: MIRA),...

Next Post

Palantir Reports Record Q4 Results, Solidifies Role in AI Revolution

Latest News

MP Materials Stock Surges on $500M Apple Deal to Boost U.S. Supply Chain

Rivian Rolls Out Custom Google Maps Integration to Elevate In-Car Navigation

BlackRock Hits $12.5 Trillion in Assets, But Revenue Miss Spurs Stock Slide

Coinbase Shares Rise as Analysts Boost Target Ahead of Crypto Policy Push

Ferrero to Acquire WK Kellogg for $3.1 Billion in Strategic Breakfast Expansion

Based on Your Interest

Distributor

Autodesk Shares Climb After Report Company Abandons PTC Acquisition Plans

July 14, 2025
bitcoin-1
Bitcoin

Bitcoin Hits Record High Above $118,000 as Institutional Inflows Surge

July 11, 2025
investing
Internet

Alibaba’s $100 Billion Wipeout Highlights Mounting Pressure in China’s Food-Delivery War

July 11, 2025

Recommended

Mega-Cap

AMD Stock Surges as Analysts See AI Chips Rivaling Nvidia’s

July 11, 2025
Bitcoin

KULR Boosts Bitcoin Holdings to Over 1,000 BTC, Reports 291% Year-to-Date BTC Yield

July 10, 2025
Airlines

Delta Reinstates 2025 Profit Outlook, But Summer Travel Outlook Lifts Shares

July 10, 2025
Ground Transportation

Uber Rides High on AV Partnerships and Strategic Momentum

July 9, 2025
Mega-Cap

Nvidia Becomes First Public Company to Top $4 Trillion in Market Value

July 9, 2025
Stoxpo

Follow us on social media:

Highlights

  • MP Materials Stock Surges on $500M Apple Deal to Boost U.S. Supply Chain
  • Rivian Rolls Out Custom Google Maps Integration to Elevate In-Car Navigation
  • BlackRock Hits $12.5 Trillion in Assets, But Revenue Miss Spurs Stock Slide
  • Coinbase Shares Rise as Analysts Boost Target Ahead of Crypto Policy Push
  • Ferrero to Acquire WK Kellogg for $3.1 Billion in Strategic Breakfast Expansion

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

mining

MP Materials Stock Surges on $500M Apple Deal to Boost U.S. Supply Chain

July 15, 2025
Rivian Electric Pickup Truck

Rivian Rolls Out Custom Google Maps Integration to Elevate In-Car Navigation

July 15, 2025
trading-chart-2

BlackRock Hits $12.5 Trillion in Assets, But Revenue Miss Spurs Stock Slide

July 15, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?